Showing results (641-650 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2018
Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn LambsShawn F L Hanson, Michael H Terry, Dafne T Moretta, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 17, 2018
Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol CrystalsAnna J Boland, Nisha Gangadharan, Pierce Kavanagh, et al.Journal of Cardiovascular Pharmacology and Therapeutics|August 29, 2023
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein CholesterolYonghong Luo, Daoquan PengJournal of Cardiovascular Pharmacology and Therapeutics|August 28, 2023
ARNI Versus Perindopril for Remodeling in HFrEF. A Cohort StudyNoor Muhammad Azlan Shah Bin Atan, Mohd Firdaus Bin Hadi, Victoria Wen Yeng Teoh, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 4, 2023
Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational StudyJia Cheng, Lin Qiu, Zixuan Zhang, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 14, 2023
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm?Rosaria Vincenza Giglio, Emir M Muzurović, Angelo Maria Patti, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Comparison of the effect of class IA antiarrhythmic drugs on transmembrane potassium currents in rabbit ventricular myocytesNorbert Iost, László Virág, András Varró, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 20, 2002
Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patientsRodolfo Carrillo-Jimenez, Gervasio A Lamas, Charles H HennekensJournal of Cardiovascular Pharmacology and Therapeutics|May 16, 2002
Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, randomized, controlled trialM R Cesarone, G Belcaro, L Incandela, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2002
Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisaprideJean T Barbey, Ralph Lazzara, Douglas P ZipesPageof 129